Thursday, November 12, 2026

GBP/EUR Over 1% Up In The Last 10 Sessions

ViaNews Editorial Team

September 30, 2024

GBP/EUR Over 1% Up In The Last 10 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 1.16% for the last 10 sessions. At 17:10 EST on Monday, 30 September, GBP/EUR (GBPEUR) is $1.20.

GBP/EUR's yearly highs and lows, it's 5.26% up from its 52-week low and 0.183% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was 0.09%, 0.03%, and 0.20%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.31% (last week), 0.19% (last month), and 0.20% (last quarter), respectively.

News about

  • Usd/jpy struggles to capitalize on modest intraday gains, up a little around mid-142.00s. According to FXStreet on Monday, 30 September, "This, along with news that the new PMI is planning a general election for October 27 and mixed Japanese economic data, undermines the Japanese Yen (JPY) and is seen lending support to the USD/JPY pair.", "The USD/JPY pair attracts some dip-buyers at the start of a new week and reverses a part of Friday's sharp retracement slide from the 146.50 area or over a three-week high. "
  • According to FXStreet on Monday, 30 September, "At press time, USD/JPY is trading 0.14% higher on the day, paring back gains to hover around 142.35."
  • According to FXStreet on Monday, 30 September, "In terms of support, the USD/JPY pair may navigate around the 139.58 region, the lowest point since June 2023.", "On the upside, a return to the ascending channel could weaken the bearish case and lead the USD/JPY pair to test the nine-day Exponential Moving Average (EMA) at the 143.10 level. "
  • Usd/jpy: bullish momentum on daily chart fades – OCBC. According to FXStreet on Monday, 30 September, "The risk she may win was one of the factors that kept USD/JPY rather supported for most of last week. ", "Last Friday, USD/JPY traded up to high of 146.49 after candidate Takaichi managed to get into run-off against Ishiba. "
  • According to FXStreet on Monday, 30 September, "Just as hopes were building that some of the recent volatility in USD/JPY was on course to die-back, Japanese political change has proved that the currency pair maintains a nervous disposition, Rabobank's FX strategist Jane Foley notes.", "Despite the changing political landscape both the Japan and in the US, we would expect central bank policy to remain the primary driver of USD/JPY over the coming months. "

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com